[Significance of plasma-protein paracoagulation test in the diagnosis of thromboembolic the disease].
Fibrinogen degradation products were examined by plasma protamine paracoagulation test in 235 cases. The test was positive in about 60% of thrombosis of deep veins, pulmonary embolism, and myocardial infarction cases examined. The test was also positive in 23,4% of women taking oral contraceptives who were free of complaints and symptoms. Because of its easy applicability the test is recommended for screening.
D000208:Acute Disease; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood; D011479:Protamines / Q000097:blood*; D011655:Pulmonary Embolism / Q000097:blood; D013923:Thromboembolism / Q000097:blood / Q000175:diagnosis*
D005338:Fibrin Fibrinogen Degradation Products; D011479:Protamines; D005340:Fibrinogen
Die Bedeutung des Plasma-Protamin-Parakoagulationstests zur Erkennung thromboembolischer Erkrankungen